AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.

By R. Russell, Ji Li, David L. Coven, M. Pypaert, C. Zechner, M. Palmeri, F. Giordano, J. Mu, M. Birnbaum, L. Young. Journal of Clinical Investigation, 2004

767 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/9d809e27ad08095334f377a08e149cd93afad16e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. K. Walsh
2. N. Ouchi
3. Haiming Cao
4. H. Fang
5. R. L. Judd

In Molecular Biology

1. D. Hardie
2. David Carling
3. B. Kahn
4. T. Alquier
5. K. Walsh
6. R. Shaw
7. G. Steinberg
8. S. Hawley

In Surgery

1. D. Hardie
2. David Carling
3. B. Kahn
4. T. Alquier
5. R. Shaw
6. B. K. Pedersen
7. S. Hawley
8. G. Steinberg

Citations in the corpus

• AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. (2005, background): “In addition, inactivation of AMPK prevented the increase in fatty acid oxidation following reperfusion of ischemic hearts (Russell et al., 2004).”
• Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms (2005, background): “Because AMP-activated protein kinase (AMPK) is reported to protect myocytes from ischemia-reperfusion injur”